Andrew Cheng
2022
In 2022, Andrew Cheng earned a total compensation of $10.4M as President and Chief Executive Officer at Akero Therapeutics, a 135% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $600,600 |
|---|---|
| Option Awards | $6,973,168 |
| Salary | $624,000 |
| Stock Awards | $2,248,475 |
| Total | $10,446,243 |
Cheng received $7M in option awards, accounting for 67% of the total pay in 2022.
Cheng also received $600.6K in non-equity incentive plan, $624K in salary and $2.2M in stock awards.
Rankings
In 2022, Andrew Cheng's compensation ranked 233rd out of 5,625 executives tracked by ExecPay. In other words, Cheng earned more than 95.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 233 out of 5,625 | 96th |
Division Manufacturing | 91 out of 3,053 | 97th |
Major group Chemicals And Allied Products | 19 out of 1,380 | 99th |
Industry group Drugs | 15 out of 1,281 | 99th |
Industry Pharmaceutical Preparations | 11 out of 927 | 99th |
Pay ratio
| Andrew Cheng's Pay | $10,446,243 |
|---|---|
| Median Employee's Pay | $515,516 |
| Pay Ratio | 20to 1 |
In 2022, the annual total compensation of Andrew Cheng was $10,446,243.
The annual total compensation of the median employee at Akero Therapeutics was $515,516.
The ratio of Andrew Cheng's pay to the pay of median employee was therefore 20 to one.
Source: SEC filing on April 28, 2023.
Cheng's colleagues
We found four more compensation records of executives who worked with Andrew Cheng at Akero Therapeutics in 2022.